With regard to the healing of corneal nerve and stem/progenitor cells, the topical administration of IGF-1 may become applicable in severe situations caused by persistent corneal ulcers in patients with type 2 diabetes. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.